April 9, 2026
Deck Bio
Deck Bio develops multi-target T cell engager immunotherapies...
- Round
- Seed
- Amount raised
- $3.1M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- Cambridge, United States
- Employees
- 1-10
- Website
- deck.bio
- —
April 9, 2026
Deck Bio develops multi-target T cell engager immunotherapies...